A Conformational Variant of p53 (U-p53AZ) as Blood-Based Biomarker for the Prediction of the Onset of Symptomatic Alzheimer’s Disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2426-0266
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A Conformational Variant of p53 (U-p53AZ) as Blood-Based Biomarker for the Prediction of the Onset of Symptomatic Alzheimer’s Disease ; volume:9 ; number:3 ; day:17 ; month:5 ; year:2022 ; pages:469-479 ; date:7.2022
The journal of prevention of Alzheimer's disease ; 9, Heft 3 (17.5.2022), 469-479, 7.2022
- Creator
-
Piccirella, Simona
Van Neste, L.
Fowler, C.
Masters, C. L.
Fripp, J.
Doecke, J. D.
Xiong, C.
Uberti, D.
Kinnon, P.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.14283/jpad.2022.52
- URN
-
urn:nbn:de:101:1-2022092022121117192216
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Piccirella, Simona
- Van Neste, L.
- Fowler, C.
- Masters, C. L.
- Fripp, J.
- Doecke, J. D.
- Xiong, C.
- Uberti, D.
- Kinnon, P.
- SpringerLink (Online service)
Other Objects (12)
Blood-based molecular biomarkers for Alzheimer’s disease
Blood‐based biomarkers for Alzheimer's disease
Blood-based lipidomic signature of severe obstructive sleep apnoea in Alzheimer’s disease
Assessment of immunoprecipitation with subsequent immunoassays for the blood-based diagnosis of Alzheimer’s disease
A blood-based composite panel that screens Alzheimer’s disease
The potential impact of clinical factors on blood-based biomarkers for Alzheimer’s disease
Blood-based biomarkers in Alzheimer’s disease – moving towards a new era of diagnostics
The impact of exercise on blood-based biomarkers of Alzheimer’s disease in cognitively unimpaired older adults
An Update on Blood-Based Markers of Alzheimer’s Disease Using the SiMoA Platform
New approaches to symptomatic treatments for Alzheimer’s disease
Patterns of use of symptomatic treatments for Alzheimer's disease dementia (AD)
Exploring small non-coding RNAs as blood-based biomarkers to predict Alzheimer’s disease
Blood-based molecular biomarkers for Alzheimer’s disease
Blood‐based biomarkers for Alzheimer's disease
Blood-based lipidomic signature of severe obstructive sleep apnoea in Alzheimer’s disease
Assessment of immunoprecipitation with subsequent immunoassays for the blood-based diagnosis of Alzheimer’s disease
A blood-based composite panel that screens Alzheimer’s disease
The potential impact of clinical factors on blood-based biomarkers for Alzheimer’s disease
Blood-based biomarkers in Alzheimer’s disease – moving towards a new era of diagnostics
The impact of exercise on blood-based biomarkers of Alzheimer’s disease in cognitively unimpaired older adults
An Update on Blood-Based Markers of Alzheimer’s Disease Using the SiMoA Platform
New approaches to symptomatic treatments for Alzheimer’s disease
Patterns of use of symptomatic treatments for Alzheimer's disease dementia (AD)
Exploring small non-coding RNAs as blood-based biomarkers to predict Alzheimer’s disease
Blood-based molecular biomarkers for Alzheimer’s disease
Blood‐based biomarkers for Alzheimer's disease
Blood-based lipidomic signature of severe obstructive sleep apnoea in Alzheimer’s disease
Assessment of immunoprecipitation with subsequent immunoassays for the blood-based diagnosis of Alzheimer’s disease
A blood-based composite panel that screens Alzheimer’s disease
The potential impact of clinical factors on blood-based biomarkers for Alzheimer’s disease
Blood-based biomarkers in Alzheimer’s disease – moving towards a new era of diagnostics
The impact of exercise on blood-based biomarkers of Alzheimer’s disease in cognitively unimpaired older adults
An Update on Blood-Based Markers of Alzheimer’s Disease Using the SiMoA Platform
New approaches to symptomatic treatments for Alzheimer’s disease
Patterns of use of symptomatic treatments for Alzheimer's disease dementia (AD)